JYD:NASDAQJayud Global Logistics Limited Analysis
Data as of 2026-06-18 - not real-time
$0.77
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Jayud Global Logistics (JYD) is trading at a level well below its longer‑term moving averages, indicating a pronounced downtrend. The price sits near the 20‑day average while the 50‑day and 200‑day averages remain comfortably above, reinforcing bearish bias. Momentum indicators show mixed signals: the RSI is in oversold territory, suggesting potential for a rebound, and the MACD has just turned bullish, hinting at short‑term upside. However, volume has been tapering and 30‑day volatility is extreme, underscoring fragile market participation. The fundamentals are starkly weak – the company reports negative earnings, cash flow deficits and a sizable debt load, yet the market valuation (price‑to‑book and price‑to‑sales) is deeply discounted. Recent retail interest and a proposed share consolidation at the upcoming AGM could provide a catalyst for a brief rally, but the underlying financial health remains a major concern.
Given the combination of a distressed balance sheet, severe price decline and a highly volatile trading environment, the stock carries substantial risk. The Chinese logistics sector adds regulatory and geographic uncertainties, and the tiny market cap limits liquidity. While the technical picture offers a speculative entry point, the long‑run outlook is constrained by ongoing losses and cash‑flow challenges. Investors should weigh the potential short‑term bounce against the pronounced fundamental weaknesses before making any commitment.
Given the combination of a distressed balance sheet, severe price decline and a highly volatile trading environment, the stock carries substantial risk. The Chinese logistics sector adds regulatory and geographic uncertainties, and the tiny market cap limits liquidity. While the technical picture offers a speculative entry point, the long‑run outlook is constrained by ongoing losses and cash‑flow challenges. Investors should weigh the potential short‑term bounce against the pronounced fundamental weaknesses before making any commitment.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI and bullish MACD suggest a near‑term technical rebound
- Retail momentum and potential share consolidation could spark buying pressure
- Deep valuation discount provides a margin of safety for speculative entry
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued cash‑flow deficits and negative earnings limit upside
- High volatility and decreasing volume may erode gains
- Uncertainty around debt servicing and regulatory environment in China
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent operating losses and weak profitability outlook
- Severe drawdown history and fragile balance sheet
- Sector and geographic headwinds outweigh valuation appeal
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin-5.93%
ROE-43.74%
ROA-10.68%
Debt/Equity35.32
P/B Ratio0.2
Op. Cash Flow$-35957112
Free Cash Flow$-22799348
Industry P/E31.2
Technical Analysis
TrendBearish
RSI32.2
Support$0.47
Resistance$1.45
MA 20$0.78
MA 50$2.82
MA 200$3.98
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.59
Volatility412.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.